IFNAR1 and systemic lupus erythematosus: In view of these potential infectious risks, full vaccination against HZ and SARS-Cov-2 (avoiding live vaccines) is strongly recommended before starting anti-IFNAR1 therapy for SLE and is probably advisable for any other biological therapy or ISA.